Dr Montaha AL-Iede MD,DCH,FRACP

Slides:



Advertisements
Similar presentations
Cystic Fibrosis Fred Hill, MA, RRT. Overview Cystic fibrosis is the most common fatal, inherited disease in the U. S. Cystic fibrosis is the most common.
Advertisements

Cystic Fibrosis Gina Brandl, RN BSN Nursing Instructor, Pediatrics.
Cystic fibrosis. Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects most critically the lungs, and also the pancreas, liver,
Pulmonary Function Testing in Cystic Fibrosis
Tiffany Rimmer.  CF is the most common lethal autosomal recessive genetic disease in Caucasians.  It affects over 30,000 individuals in the United States.
CYSTIC FIBROSIS FANOURAKI MARIA CHARALAMPIDOU ALEXANDRA
Cystic Fibrosis Paolo Aquino Internal Medicine-Pediatrics January 13, 2005.
The genetics of cystic fibrosis
1 RETROSPECTIVE EVALUATION OF THE PATIENTS WITH CYSTIC FIBROSIS DR.LALE PULAT SEREN ZEYNEP KAMİL MATERNITY AND CHILDREN’S TRAINING AND RESEARCH HOSPITAL.
By Taliyah and Selina. Cystic Fibrosis CF Mucoviscidosis.
The Child with Cystic Fibrosis Lydia Burland. Learning Outcomes By the end of the session you should;  Know the basic physiology underlying CF  Recognise.
IIt is a genetic disease that is passed down through families that causes a thick, sticky mucus to build up in the lungs, digestive tract, and other.
Symptoms In newborns: – Delayed growth – Failure to gain weight normally during childhood – No bowel movements in first 24 to 48 hours of life – Salty-tasting.
Respiratory system. The primary function of the respiratory system is the supply of oxygen to the blood and the removal of carbon dioxide.
Patient: Lily Johnson Case study by Alexa Angelo
Cystic fibrosis CF. Cysticfibrosis Cystic fibrosis the most common autosomal recessive (AR) disorder among Caucasians chronic and progressive disease.
Cystic Fibrosis Islamic university Nursing College.
Bronchiectasis Sami ur Rahman Roll No: Overview Definition Etiology Pathology Clinical Presentation Diagnosis Treatment.
Sweat Test. A sweat test measures the amount of salt chemicals (sodium and chloride) in sweat. Sodium and chloride are part of your body’s electrolyte.
Cystic Fibrosis By: Morgan. Definition Cystic fibrosis is a thick mucus that clogs the air ways and tends to cause lung diseases. A diseases common among.
Cystic Fibrosis: A Review for Healthcare Providers
.  Pancreas is a large gland  Involved in the digestive process but located outside the GI tract  Composed of both exocrine and endocrine functions.
Cystic fibrosis is an inherited disease that causes thick, sticky mucus to build up in the lungs and digestive tract.
Essay marking scheme 0: No answer 2 : Fail. Very incomplete or very inaccurate answer, or answer indicating substantial and potentially dangerous misunderstanding.
Cystic Fibrosis Hereditary recessive trait disease
Cystic Fibrosis Board Review February 11, Cystic Fibrosis b Mutation in CFTR gene--epithelial chloride channels mutation causes decreased Cl transport.
Objectives Review the causes of cystic fibrosis (CF) Describe the symptoms and laboratory findings in CF Review current and emerging CF treatments Review.
Cystic Fibrosis "Woe to that child which when kissed on the forehead tastes salty. He is bewitched and soon must die." This European adage accurately describes.
CYSTIC FIBROSIS AND CELL COMMUNICATION. CFTR Cystic Fibrosis Transmembrane Conductance Regulator ( Or CFTR)  Is a transport protein for Chloride across.
MAJOR EVENTS AND EVOLUTION IN CYSTIC FIBROSIS PATIENTS Author: Alexandra Martin Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy Târgu-
Cystic Fibrosis.
LAUREN BURNETT NUR3215 EBP CYSTIC FIBROSIS. OBJECTIVES By completion of this presentation, learners should be able to: Describe the effects Cystic Fibrosis.
Management of Patients With Chronic Pulmonary Disease
New Developments in Cystic Fibrosis
Cystic Fibrosis Overview
Cystic Fibrosis and Termination of Pregnancy Jalandria Gurley, MS, FNP-BC Texas Woman’s University.
Other names for cystic fibrosis are CF, Pancreas fibrocystic disease, and Pancreatic cystic fibrosis. The name was chosen because cystic means biliary.
+ DIOS: A Dietitian’s Perspective Michelle Stroebe, MS RD Adult Cystic Fibrosis Center Stanford Healthcare.
BY: TERESA KRASZEWSKI CYSTIC FIBROSIS. BACKGROUND AND HISTORY Late 16th century babies who had “salty skin” when kissed were likely to die 1938 Dr. Dorothy.
༜ A sweat test measures the amount of salt chemicals (sodium and chloride) in sweat. ༜ Sodium and chloride are part of your body’s electrolyte balance,
Cystic Fibrosis By:YaYPhineas(Edward). What is Cystic Fibrosis? A genetic disorder that affects your digestive and respiratory system You inherit a defective.
Cystic fibrosis. Etiology and epidemiology Cystic fibrosis (CF) is an autosomal recessive disorder that is the most common life limiting genetic disease.
Cystic Fibrosis Done by : Layan Talib Marwa Adil Marwa Abdulsatar
Nutrition and Cystic Fibrosis
Cystic fibrosis.
Cystic Fibrosis Chris Kingsnorth.
CF Is not just CF.
Cell Membrane Structure and Function
Cystic fibrosis BY: NATALIE ALZAGA STEPHANY GODINEZ STEPHANY TORO
Nuts and Bolts: Pulmonary Overview Starla G. Martinez, M. D
Mutations.
Cystic Fibrosis - Clinical and Genetic Aspects
Cystic Fibrosis By James Gray 2012.
Cystic Fibrosis Richard H. Simon Pulmonary and Critical Care Medicine Department of Internal Medicine Fall 2008.
Sweat Test.
Lab 13 Sweat Test.
Mutations
Mutations
Cystic fibrosis Parul Shrestha.
CYSTIC FIBROSIS (CF) © 2016 Paul Billiet ODWS.
Cystic Fibrosis Bryan Chua.
Inherited Metabolic Disorders
Cystic Fibrosis An Overview
Mutations.
Long Term Respiratory Dysfunction
Dr. Pratima Ghimire June, 2009
Mutations
Review of Anatomy and Physiology
Mutations in the CFTR gene that lead to defective Cl– and other ion transport through CFTR protein channels are the underlying defect of CF CFTR gene mutations.
Presentation transcript:

Dr Montaha AL-Iede MD,DCH,FRACP Paediatric Pulmonologist & Sleep physician

CF is a life-shortening, multisystem genetic disease. First described by Dr. Dorothy Anderson (American Pathologist). provided the first description of the disorder in 1938. Mutated CF gene (cystic fibrosis trans-membrane conductance regulator; CFTR) was discovered in 1989. The function of CFTR protein discovered in 1992

Characterized by: chronic, progressive obstructive lung disease Other systemic manifestations, such as: nutrient malabsorption and malnutrition due to pancreatic insufficiency. liver disease and cirrhosis, and CF-related diabetes mellitus (CFRD).

Median survival has improved steadily from less than 2 years (1938) to 41.1 years currently. This results from: early diagnosis implementation of therapies to optimize lung health and nutritional status treat chronic respiratory infection, and improve quality of life.

Prevalence: CF is common in the Caucasian population but does occur in all ethnic and racial groups. Occurs in approximately 1: 3000 live births. Genet Med. 2008 M/C gene mutated : delta F508

Genetics • Autosomal recessive • 1 in 30 Caucasians are carriers • 1 in 3300 live births in Caucasians • US ~30,000 affected individuals • Other ethnicities - incidences in US – Hispanic: 1:9000 – African American: 1:15,000 – Asian: 1:32,000 CFF.org. Accessed August 2013. Rohlfs E, et al. Clin Chem. 2011;57:841-848.

CFTR Gene Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) • Long arm chr 7 (7q31.2) • Large gene: 189 kilobases, 27 exons • Transcribed into 6.5 kb mRNA • Encodes 1480 amino acids * Regulates chloride movement in and out of a range of epithelial cells.

CF Mutations Over 1900 CFTR mutations • F508del most common – Homozygous – 47% – Heterozygous – 40% • Other mutations – G542X – 5% – G551D – 4% – R117H – 3% – N1303K – 2.5% – 2789+5G>A – 1.3% CFF Patient Registry. www.cff.org. Accessed Aug 2013

Mutation Mutation class Effect on CFTR protein Relative frequency [%] ΔF508 II Block in protein processing 66.0 G542X I Reduced or absent synthesis 2.4 G551D III Block in regulation of CFTR chloride channel 1.6 N1303K 1.3 W1282X 1.2 R553X 0.7 621 + IG>T 1717-IG>A 0.6 R117H IV Altered conductance of CFTR chloride channel 0.3 R1162X

Diagnosis: Criteria - One of the following . Presence of typical clinical features . History of CF in a sibling . Positive newborn screening test - Plus laboratory evidence for CFTR dysfunction . Two elevated sweat chloride concentration on 2 separate days . Identification of 2 CF mutations . Abnormal nasal potential difference measurement

Diagnostic Testing: Newborn Screening test: pancreatic derived enzyme immunoreactive trypsinogen [IRT] Sweat Chloride: the most useful test for diagnosing CF.  ≥60 mmol/L Genetic testing The standard diagnostic test for pancreatic insufficiency has been the three day fat collection.

Sweat Chloride testing: IF NBS +ve: Sweat Cl testing when the infant weighs >2 kg, and is at least 36 wk of corrected gestational age. Newborns greater than 36 wk gestation and >2 kg body weight with a positive CF newborn screen, should have sweat chloride testing performed as soon as possible after 10 d of age, ideally by the end of the neonatal period (4 wk of age). In children </= 6 months: sweat Cl <30 is negative, 30-59 is An intermediate sweat chloride value ( consider extended CFTR gene analysis), >/= 60 mmol/l …CF

CF Pathophysiology CFTR gene defect Defective ion transport Airway surface liquid depletion Defective mucociliary clearance Mucus obstruction Infection Inflammation

Pathophysiology Gastrointestinal: - Pancreas - Absence of CFTR limits function of chloride-bicarbonate exchanger to secrete bicarbonate. - Leads to retention of enzymes in the pancreas, destruction of pancreatic tissues.

Pathophysiology - Intestine - Decrease in water secretion leads to thickened mucus and desiccated intraluminal contents. - Obstruction of small and large intestines -Biliary Tree: - Retention of biliary secretion - Focal biliary cirrhosis - Bile duct proliferation. - Chronic cholecystitis, cholelithiasis

Manifestations Common presentation: - Chronic cough - Recurrent pulmonary infiltrates - Failure to thrive - Meconium ileus

Manifestations: Respiratory tract: - Chronic sinusitis. . Nasal obstruction . Rhinorrhea . Nasal polyps in 25%; often requires surgery - Chronic Cough: . Persistent . Viscous, purulent, green sputum

Manifestations - Infection: . Initially with H. influenza and S. aureus . Subsequently P aeruginosa . Occassionally, Burkholderia gladioli, proteus, E. coli, klebsiella. Lung Function: . Small airway disease is first functional lung abnormality . Progresses to reversible as well as irreversible changes in FEV1 . Chest x-ray may show hyperinflation, mucus impaction, bronchial cuffing, bronchiectasis

Complications Respiratory Tract: . Pneumothorax : 10% of CF pts . Hemoptysis . Digital clubbing . Cor pulmonale . Respiratory failure

Complications Gastrointestinal: - Meconium ileus . Abdominal distention . Failure to pass stool . Emesis - DIOS: distal intestinal obstruction syndrome . RLQ pain . Loss of appetite . Palpable mass . May be confused with appendicitis

Gastrointestinal complications - Exocrine pancreatic insufficiency . Found in > 90% of CFpts . Protein and fat malabsorption . Frequent bulky, foul-smelling stools . Vitamins A,K,E,D malabsorption - Increased incidence of GI malignancy

Genitourinary Late onset puberty . Due to CLD and inadequate nutrition. >95% of male pts with CF have azospermia due to obliteration of the vas dererens 20% of female pts with CF are infertile

Treatment Major objectives: - Promote clearance of secretions - Control Lung infection - Provide adequate nutrition. - Prevent intestinal obstruction

TTT: Lung > 90% of CF pts die from complications of lung infection Antibiotics: - Early intervention, long course, high dose - Staphylococcus-anti staph: fluclox - Pseudomonas-treated with two drugs with different mechanisms to prevent resistance- e.g: cephalosporin (ceftazidime) + aminoglycoside(amikacin, gentamicin) - Use of aerosolized antibiotics

Lung Increasing mucus clearance . Long-term DNAse treatment increase time between pulmonary exacerbations . Inhaled beta-adrenergic agonists to control airway constriction . Oral glucocorticoids for allergic Bronchopulmonary aspergillosis (ABPA)

Lung: - Atelectasis . Chest PT + antibiotic Respiratory Failure and cor pulmonary . Vigorous medical management . Oxygen supplementation . NIV . Lung transplantation

Treatment Gastrointestinal: - Pancreatic enzyme replacement - Replacement of fat-soluble vitamins- especially Vitamin E & K - insulin for hyperglycemia - Intestinal obstruction . Pancreatic enzymes (creon) +osmotically active agents . Distal-hypertonic radio contrast material via enema

TTT: Gastrointestinal End-stage liver disease- transplantation . 2 year survival rate >50%

Complexity of CF Treatment Bregnballe, et al. Patient Prefer Adherence. 2011;5:507-15. Sawicki, et al. Pediatr Pulmonol. 2012;47(6):523-33

Summary CF is an inherited monogenic disorder presenting as a multisystem disease Pathophysiology is related to abnormal ion transportation across epithelia Respiratory, GI and GU manifestations Treatment is currently preventative and supportive

THANK YOU